Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Envoy Medical Inc.

    NASDAQ: COCH · Real-Time Price · USD
    1.41
    -0.03 (-2.08%)
    At close: Jun 13, 2025, 3:59 PM
    1.37
    -2.84%
    After-hours: Jun 13, 2025, 04:00 PM EDT

    Envoy Medical Statistics

    Share Statistics

    Envoy Medical has 21.33M shares outstanding. The number of shares has increased by 8.64% in one year.

    Shares Outstanding

    n/a
    		 21.33M

    Shares Change (YoY)

    n/a
    		 8.64%

    Shares Change (QoQ)

    n/a
    		 5.18%

    Owned by Institutions (%)

    n/a
    		 10.78%

    Shares Floating

    n/a
    		 10.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,676

    FTD / Avg. Volume

    n/a
    		 8.01%

    Short Selling Information

    The latest short interest is 100.69K, so 0.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 100.69K

    Short % of Shares Out

    n/a
    		 0.47%

    Short % of Float

    n/a
    		 0.94%

    Short Ratio (days to cover)

    n/a
    		 3.5

    Valuation Ratios

    The PE ratio is -1.29 and the forward PE ratio is -1.07. Envoy Medical's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.29

    Forward PE

    n/a
    		 -1.07

    PS Ratio

    n/a
    		 119.42

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 -1.43

    P/FCF Ratio

    n/a
    		 -1.42

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Envoy Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.24, with a Debt / Equity ratio of -1.04.

    Current Ratio

    n/a
    		 1.24

    Quick Ratio

    n/a
    		 1.02

    Debt / Equity

    n/a
    		 -1.04

    Debt / EBITDA

    n/a
    		 -0.99

    Debt / FCF

    n/a
    		 -1.04

    Interest Coverage

    n/a
    		 -23.6

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $5,357.14

    Profits Per Employee

    n/a
    		 $-495,119.05

    Employee Count

    n/a
    		 42

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 0.43

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -46.18% in the last 52 weeks. The beta is 2.27, so Envoy Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.27

    52-Week Price Change

    n/a
    		 -46.18%

    50-Day Moving Average

    n/a
    		 1.47

    200-Day Moving Average

    n/a
    		 1.94

    Relative Strength Index (RSI)

    n/a
    		 39.66

    Average Volume (20 Days)

    n/a
    		 20,911

    Income Statement

    In the last 12 months, Envoy Medical had revenue of 225K and earned -20.8M in profits. Earnings per share was -1.49.

    Revenue

    n/a
    		 225K

    Gross Profit

    n/a
    		 -517K

    Operating Income

    n/a
    		 -19.26M

    Net Income

    n/a
    		 -20.8M

    EBITDA

    n/a
    		 -19.81M

    EBIT

    n/a
    		 -19.98M

    Earnings Per Share (EPS)

    n/a
    		 -1.49
    Full Income Statement

    Balance Sheet

    The company has 5.48M in cash and 19.66M in debt, giving a net cash position of -14.18M.

    Cash & Cash Equivalents

    n/a
    		 5.48M

    Total Debt

    n/a
    		 19.66M

    Net Cash

    n/a
    		 -14.18M

    Retained Earnings

    n/a
    		 -284.73M

    Total Assets

    n/a
    		 10.38M

    Working Capital

    n/a
    		 717K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.95M and capital expenditures -980K, giving a free cash flow of -18.93M.

    Operating Cash Flow

    n/a
    		 -17.95M

    Capital Expenditures

    n/a
    		 -980K

    Free Cash Flow

    n/a
    		 -18.93M

    FCF Per Share

    n/a
    		 -1.01
    Full Cash Flow Statement

    Margins

    Gross margin is -229.78%, with operating and profit margins of -8558.22% and -9242.22%.

    Gross Margin

    n/a
    		 -229.78%

    Operating Margin

    n/a
    		 -8558.22%

    Pretax Margin

    n/a
    		 -9242.22%

    Profit Margin

    n/a
    		 -9242.22%

    EBITDA Margin

    n/a
    		 -8802.67%

    EBIT Margin

    n/a
    		 -8558.22%

    FCF Margin

    n/a
    		 -8412.89%

    Dividends & Yields

    COCH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for COCH is $9.25, which is 556% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $9.25

    Price Target Difference

    n/a
    		 556%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -42.9

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist